User profiles for Brian P. Brennan
Brian P. BrennanMcLean Hospital, Harvard Medical School Verified email at partners.org Cited by 2315 |
Subcortical brain volume, regional cortical thickness, and cortical surface area across disorders: findings from the ENIGMA ADHD, ASD, and OCD working groups
…, D Brandeis, S Brem, BP Brennan… - American Journal of …, 2020 - Am Psychiatric Assoc
Objective: Attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD),
and obsessive-compulsive disorder (OCD) are common neurodevelopmental disorders that …
and obsessive-compulsive disorder (OCD) are common neurodevelopmental disorders that …
Virtual histology of cortical thickness and shared neurobiology in 6 psychiatric disorders
…, S Borgwardt, D Brandeis, BP Brennan… - JAMA …, 2021 - jamanetwork.com
Importance Large-scale neuroimaging studies have revealed group differences in cortical
thickness across many psychiatric disorders. The underlying neurobiology behind these …
thickness across many psychiatric disorders. The underlying neurobiology behind these …
[HTML][HTML] Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole
BP Brennan, JI Hudson, JE Jensen… - …, 2010 - nature.com
Glutamatergic abnormalities may underlie bipolar disorder (BD). The glutamate-modulating
drug riluzole may be efficacious in bipolar depression, but few in vivo studies have …
drug riluzole may be efficacious in bipolar depression, but few in vivo studies have …
A critical review of magnetic resonance spectroscopy studies of obsessive-compulsive disorder
Functional neuroimaging studies have converged to suggest that cortico-striatal-thalamo-cortical
(CSTC) circuit dysfunction is a core pathophysiologic feature of obsessive-compulsive …
(CSTC) circuit dysfunction is a core pathophysiologic feature of obsessive-compulsive …
Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder: a review
Importance Obsessive-compulsive disorder (OCD) is a common and often debilitating
psychiatric illness. Recent advances in the understanding of the neuroscience of OCD have …
psychiatric illness. Recent advances in the understanding of the neuroscience of OCD have …
Brain and cognition abnormalities in long-term anabolic-androgenic steroid users
Background Anabolic-androgenic steroid (AAS) use is associated with psychiatric symptoms
including increased aggression as well as with cognitive dysfunction. The brain effects of …
including increased aggression as well as with cognitive dysfunction. The brain effects of …
An overview of the first 5 years of the ENIGMA obsessive–compulsive disorder working group: The power of worldwide collaboration
…, I Bollettini, A Bose, BP Brennan… - Human brain …, 2022 - Wiley Online Library
Neuroimaging has played an important part in advancing our understanding of the neurobiology
of obsessive–compulsive disorder (OCD). At the same time, neuroimaging studies of …
of obsessive–compulsive disorder (OCD). At the same time, neuroimaging studies of …
[HTML][HTML] Performing group-level functional image analyses based on homologous functional regions mapped in individuals
Functional MRI (fMRI) studies have traditionally relied on intersubject normalization based
on global brain morphology, which cannot establish proper functional correspondence …
on global brain morphology, which cannot establish proper functional correspondence …
Mapping cortical and subcortical asymmetry in obsessive-compulsive disorder: findings from the ENIGMA consortium
Background Lateralized dysfunction has been suggested in obsessive-compulsive disorder
(OCD). However, it is currently unclear whether OCD is characterized by abnormal patterns …
(OCD). However, it is currently unclear whether OCD is characterized by abnormal patterns …
Duloxetine in the treatment of irritable bowel syndrome: an open‐label pilot study
BP Brennan, KV Fogarty, JL Roberts… - Human …, 2009 - Wiley Online Library
Objective To assess the efficacy of duloxetine for irritable bowel syndrome (IBS). Methods
We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS …
We conducted an open‐label 12‐week trial of duloxetine 60 mg daily in 15 patients with IBS …